IRIS UniCatt

Trecarichi, Enrico Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.827
NA - Nord America 3.452
AS - Asia 3.125
SA - Sud America 551
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 12.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.352
DE - Germania 2.574
CN - Cina 1.294
SG - Singapore 1.187
SE - Svezia 545
BR - Brasile 435
IT - Italia 347
UA - Ucraina 296
GB - Regno Unito 272
FR - Francia 261
IE - Irlanda 134
VN - Vietnam 128
IN - India 100
TR - Turchia 94
FI - Finlandia 92
ID - Indonesia 87
PL - Polonia 83
RU - Federazione Russa 71
AR - Argentina 49
CA - Canada 49
BD - Bangladesh 44
HK - Hong Kong 34
MX - Messico 34
BE - Belgio 25
IQ - Iraq 24
NL - Olanda 23
JP - Giappone 19
EC - Ecuador 18
CO - Colombia 16
ES - Italia 14
VE - Venezuela 13
RO - Romania 12
AT - Austria 11
IR - Iran 11
ZA - Sudafrica 11
SA - Arabia Saudita 10
PK - Pakistan 9
AZ - Azerbaigian 8
CI - Costa d'Avorio 8
IL - Israele 8
KR - Corea 8
AU - Australia 7
CH - Svizzera 7
JM - Giamaica 7
JO - Giordania 7
KZ - Kazakistan 7
LT - Lituania 7
UZ - Uzbekistan 7
BG - Bulgaria 6
EU - Europa 6
MA - Marocco 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HU - Ungheria 5
NP - Nepal 5
RS - Serbia 5
UY - Uruguay 5
VA - Santa Sede (Città del Vaticano) 5
AL - Albania 4
BO - Bolivia 4
EG - Egitto 4
ET - Etiopia 4
LV - Lettonia 4
PE - Perù 4
PY - Paraguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BN - Brunei Darussalam 3
CL - Cile 3
CR - Costa Rica 3
HR - Croazia 3
KE - Kenya 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TN - Tunisia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CM - Camerun 2
CY - Cipro 2
DJ - Gibuti 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ME - Montenegro 2
MU - Mauritius 2
MY - Malesia 2
NI - Nicaragua 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
Totale 12.020
Salva come PNG Salva come JPEG
Città #
Singapore 558
Chandler 552
Hangzhou 440
Ashburn 301
Jacksonville 205
Nürnberg 202
Beijing 198
San Mateo 153
Ann Arbor 144
Nanjing 136
Dublin 133
Dearborn 118
Los Angeles 96
New York 96
Jakarta 81
Wilmington 81
Izmir 75
Milan 68
Munich 64
Woodbridge 63
Boston 60
Lawrence 56
Kraków 55
Marseille 55
Hefei 53
Moscow 53
Nanchang 52
Houston 50
Cattolica 45
Buffalo 44
Redwood City 44
São Paulo 40
Ho Chi Minh City 38
Seattle 38
Bremen 37
Chicago 37
Hanoi 37
Frankfurt am Main 35
Hong Kong 32
Kunming 31
Tianjin 29
Shenyang 27
Rome 26
Brussels 25
The Dalles 25
Dallas 24
Mountain View 22
Hebei 21
Helsinki 21
Princeton 21
Brooklyn 20
Norwalk 20
Changsha 18
Toronto 18
Guangzhou 17
Leawood 17
Redmond 17
Shanghai 17
Boardman 16
Lancaster 16
Santa Clara 16
Warsaw 16
University Park 15
Fairfield 14
Jinan 14
Zhengzhou 14
Fremont 13
London 13
Mexico City 13
Rio de Janeiro 13
Augusta 12
Costa Mesa 12
Stockholm 12
Tokyo 12
Belo Horizonte 11
Hải Dương 11
Jiaxing 11
Montreal 11
Orem 11
Denver 10
Nuremberg 10
Auburn Hills 9
Brasília 9
Kent 9
Roubaix 9
San Jose 9
Abidjan 8
Atlanta 8
Chennai 8
Düsseldorf 8
Ningbo 8
Pune 8
Seoul 8
Amman 7
Baghdad 7
Baku 7
Erbil 7
Guayaquil 7
Hyderabad 7
Miami 7
Totale 5.487
Salva come PNG Salva come JPEG
Nome #
Factors associated with mortality in bacteremic patients with hematologic malignancies. 345
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 344
Factors associated with mortality in bacteremic patients with haematologic malignancies 337
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 337
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 297
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 287
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 285
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 255
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 226
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 217
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 214
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 207
Factors associated with mortality in bacteremic patients with hematologic malignancies. 205
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 199
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 198
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 188
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 178
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 177
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 174
Safety and effectiveness of transvenous lead extraction in octogenarians 172
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 169
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 167
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 166
Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome 166
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 166
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 162
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 162
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 159
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 151
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 149
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 147
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 146
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 145
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 143
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 140
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 137
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 136
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 136
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 136
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 135
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 134
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 132
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 129
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 128
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 127
Mortality in patients with early- or late-onset candidaemia 123
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 122
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 121
Uncommon yeast infections in hematological patients: from diagnosis to treatment 120
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 120
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 120
Mortality in patients, with early-or late-onset candidaemia 119
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 119
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 119
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study 114
Epidemiological and clinical features of pyogenic spondylodiscitis. 112
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 112
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 108
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 107
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 106
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 103
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 101
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 99
Mortality in patients with early- or late-onset candidaemia 98
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 97
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 97
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 95
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 92
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia 88
Isavuconazole-Animal Data and Clinical Data 84
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections 81
When Viruses Meet Fungi: Tackling the Enemies in Hematology 81
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 78
Mortality in patients with early- or late-onset candidaemia 77
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 72
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 72
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 69
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 64
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 62
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 61
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 57
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 55
New advances in management and treatment of cardiac implantable electronic devices infections 49
Bloodstream infections caused by extended-spectrum-β-lactamase- producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy 44
Totale 12.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.631
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021397 0 0 0 0 0 52 64 29 107 15 117 13
2021/2022856 83 83 47 48 52 39 12 140 38 63 116 135
2022/20231.567 191 223 115 246 89 196 86 126 176 29 69 21
2023/2024649 39 198 13 26 19 91 48 23 9 25 81 77
2024/20251.371 50 35 109 30 171 51 41 56 213 99 280 236
2025/20262.230 568 97 209 442 759 155 0 0 0 0 0 0
Totale 12.128